Literature DB >> 30734369

Using an old test for new tricks: Measuring direct oral anti-Xa drug levels by conventional heparin-calibrated anti-Xa assay.

Cheryl L Maier1, William H Asbury2, Alexander Duncan1,3, Adele Robbins2, Ann Ingle3, Adam Webb4, Sean R Stowell1, John D Roback1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30734369      PMCID： PMC8668051          DOI： 10.1002/ajh.25434

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  6 in total

1.  Heparin-calibrated chromogenic anti-Xa assays are not suitable to assess the presence of significant direct factor Xa inhibitors levels.

Authors:  Lina Sabor; Mélanie Raphaël; Jean-Michel Dogné; François Mullier; Jonathan Douxfils
Journal:  Thromb Res       Date:  2017-05-25       Impact factor: 3.944

2.  Heparin-Calibrated Chromogenic Anti-Xa Activity Measurements in Patients Receiving Rivaroxaban: Can This Test Be Used to Quantify Drug Level?

Authors:  Robert C Gosselin; Suzanne J Francart; Emily M Hawes; Stephan Moll; William E Dager; Dorothy M Adcock
Journal:  Ann Pharmacother       Date:  2015-04-08       Impact factor: 3.154

3.  Andexanet Alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors.

Authors:  Stuart J Connolly; Truman J Milling; John W Eikelboom; C Michael Gibson; John T Curnutte; Alex Gold; Michele D Bronson; Genmin Lu; Pamela B Conley; Peter Verhamme; Jeannot Schmidt; Saskia Middeldorp; Alexander T Cohen; Jan Beyer-Westendorf; Pierre Albaladejo; Jose Lopez-Sendon; Shelly Goodman; Janet Leeds; Brian L Wiens; Deborah M Siegal; Elena Zotova; Brandi Meeks; Juliet Nakamya; W Ting Lim; Mark Crowther
Journal:  N Engl J Med       Date:  2016-08-30       Impact factor: 91.245

4.  Evaluation of a Heparin-Calibrated Antifactor Xa Assay for Measuring the Anticoagulant Effect of Oral Direct Xa Inhibitors.

Authors:  Jacob Beyer; Toby Trujillo; Sheila Fisher; Ann Ko; Stuart E Lind; Tyree H Kiser
Journal:  Clin Appl Thromb Hemost       Date:  2016-02-02       Impact factor: 2.389

Review 5.  Testing and monitoring direct oral anticoagulants.

Authors:  Jean M Connors
Journal:  Blood       Date:  2018-09-10       Impact factor: 22.113

Review 6.  When and how to use antidotes for the reversal of direct oral anticoagulants: guidance from the SSC of the ISTH.

Authors:  J H Levy; W Ageno; N C Chan; M Crowther; P Verhamme; J I Weitz
Journal:  J Thromb Haemost       Date:  2016-02-17       Impact factor: 5.824
  6 in total
  3 in total

1.  Author Reply to "Intravenous thrombolysis in patients taking direct oral anticoagulants (European stroke organisation intravenous thrombolysis guidelines comment).

Authors:  Gian Marco De Marchis; Guillaume Turc; William Whiteley; Georgios Tsivgoulis
Journal:  Eur Stroke J       Date:  2021-11-15

Review 2.  Anticoagulation Monitoring for Perioperative Physicians.

Authors:  Cheryl L Maier; Roman M Sniecinski
Journal:  Anesthesiology       Date:  2021-10-01       Impact factor: 8.986

3.  Accuracy of a Single, Heparin-Calibrated Anti-Xa Assay for the Measurement of Rivaroxaban, Apixaban, and Edoxaban Drug Concentrations: A Prospective Cross-Sectional Study.

Authors:  Tamana Meihandoest; Jan-Dirk Studt; Adriana Mendez; Lorenzo Alberio; Pierre Fontana; Walter A Wuillemin; Adrian Schmidt; Lukas Graf; Bernhard Gerber; Ursula Amstutz; Cedric Bovet; Thomas C Sauter; Lars M Asmis; Michael Nagler
Journal:  Front Cardiovasc Med       Date:  2022-03-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.